Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 747830, 5 pages
http://dx.doi.org/10.1155/2015/747830
Research Article

Litsea japonica Extract Inhibits Aldose Reductase Activity and Hyperglycemia-Induced Lenticular Sorbitol Accumulation in db/db Mice

Korean Medicine Based Herbal Drug Development Group, Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 305-811, Republic of Korea

Received 10 December 2014; Accepted 4 February 2015

Academic Editor: Mayank Thakur

Copyright © 2015 Junghyun Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Kyselova, M. Stefek, and V. Bauer, “Pharmacological prevention of diabetic cataract,” Journal of Diabetes and Its Complications, vol. 18, no. 2, pp. 129–140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Y. Reddy, N. V. Giridharan, and G. B. Reddy, “Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats,” Molecular Vision, vol. 18, pp. 495–503, 2012. View at Google Scholar · View at Scopus
  3. A. Bhatnagar and S. K. Srivastava, “Aldose reductase: congenial and injurious profiles of an enigmatic enzyme,” Biochemical Medicine and Metabolic Biology, vol. 48, no. 2, pp. 91–121, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. K. H. Gabbay, “The sorbitol pathway and the complications of diabetes,” The New England Journal of Medicine, vol. 288, no. 16, pp. 831–836, 1973. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Suryanarayana, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy, and G. B. Reddy, “Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats,” Investigative Ophthalmology & Visual Science, vol. 46, no. 6, pp. 2092–2099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. D. Varma, S. S. Shocket, and R. D. Richards, “Implications of aldose reductase in cataracts in human diabetes,” Investigative Ophthalmology & Visual Science, vol. 18, no. 3, pp. 237–241, 1979. View at Google Scholar · View at Scopus
  7. T. Onoda, C. Ishikawa, T. Fukazawa, W. Li, M. Obayashi, and K. Koike, “Inhibitory activities of selected Kampo formulations on human aldose reductase,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 435, 2014. View at Publisher · View at Google Scholar
  8. S.-Y. Lee, B.-S. Min, J.-H. Kim et al., “Flavonoids from the leaves of Litsea japonica and their anti-complement activity,” Phytotherapy Research, vol. 19, no. 4, pp. 273–276, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. J. Sohn, J. Kim, C.-S. Kim et al., “The extract of Litsea japonica reduced the development of diabetic nephropathy via the inhibition of advanced glycation end products accumulation in db/db mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 769416, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Kim, C. S. Kim, I. S. Lee et al., “Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice,” Endocrine, vol. 46, no. 6, pp. 462–469, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. S. Kim, N. H. Kim, D. H. Jung et al., “Genistein inhibits aldose reductase activity and high glucose-induced TGF-β2 expression in human lens epithelial cells,” European Journal of Pharmacology, vol. 594, no. 1–3, pp. 18–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. P. V. Rao and K. S. Bhat, “Effect of riboflavin deficiency on sorbitol pathway in rat lens,” Nutrition Research, vol. 9, no. 10, pp. 1143–1149, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Halder, S. Joshi, and S. K. Gupta, “Lens aldose reductase inhibiting potential of some indigenous plants,” Journal of Ethnopharmacology, vol. 86, no. 1, pp. 113–116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Suryanarayana, P. Anil Kumar, M. Saraswat, J. M. Petrash, and G. B. Reddy, “Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract,” Molecular Vision, vol. 10, pp. 148–154, 2004. View at Google Scholar · View at Scopus
  15. R. van Heyningen, “Formation of polyols by the lens of the rat with ‘sugar’ cataract,” Nature, vol. 184, no. 4681, pp. 194–195, 1959. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. Kinoshita, “A thirty year journey in the polyol pathway,” Experimental Eye Research, vol. 50, no. 6, pp. 567–573, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Nagaraj and C. Sady, “The presence of a glucose-derived Maillard reaction product in the human lens,” FEBS Letters, vol. 382, no. 3, pp. 234–238, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Simard-Duquesne, E. Greselin, J. Dubuc, and D. Dvornik, “The effects of a new aldose reductase inhibitor (Tolrestat) in galactosemic and diabetic rats,” Metabolism: Clinical and Experimental, vol. 34, no. 10, pp. 885–892, 1985. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Terashima, K. Hama, R. Yamamoto et al., “Effects of a new aldose reductase inhibitor on various tissues in vitro,” Journal of Pharmacology and Experimental Therapeutics, vol. 229, no. 1, pp. 226–230, 1984. View at Google Scholar · View at Scopus
  20. K. Mizuno, N. Kato, A. Matsubara, K. Nakano, and M. Kurono, “Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats,” Metabolism: Clinical and Experimental, vol. 41, no. 10, pp. 1081–1086, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Matsui, Y. Nakamura, H. Ishikawa, A. Matsuura, and F. Kobayashi, “Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats,” Japanese Journal of Pharmacology, vol. 64, no. 2, pp. 115–124, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Dvornik, N. Simard-Duquesne, M. Krami et al., “Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor,” Science, vol. 182, no. 4117, pp. 1146–1148, 1973. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Veeresham, A. Rama Rao, and K. Asres, “Aldose reductase inhibitors of plant origin,” Phytotherapy Research, vol. 28, no. 3, pp. 317–333, 2014. View at Google Scholar
  24. Y. S. Kim, D. H. Jung, I. S. Lee et al., “Effects of Allium victorialis leaf extracts and its single compounds on aldose reductase, advanced glycation end products and TGF-β1 expression in mesangial cells,” BMC Complementary and Alternative Medicine, vol. 13, article 251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. K. R. Ajish, K. A. Antu, M. P. Riya et al., “Studies on α-glucosidase, aldose reductase and glycation inhibitory properties of sesquiterpenes and flavonoids of Zingiber zerumbet Smith,” Natural Product Research, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  26. S. M. Lee, I. G. Ko, S. E. Kim, D. H. Kim, and B. N. Kang, “Protective effect of catechin on apoptosis of the lens epithelium in rats with N-methyl-N-nitrosourea-induced cataracts,” Korean Journal of Ophthalmology, vol. 24, no. 2, pp. 101–107, 2010. View at Publisher · View at Google Scholar · View at Scopus